{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:31:25Z","timestamp":1776814285618,"version":"3.51.2"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,1,12]],"date-time":"2013-01-12T00:00:00Z","timestamp":1357948800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s10620-012-2527-3","type":"journal-article","created":{"date-parts":[[2013,1,11]],"date-time":"2013-01-11T03:11:46Z","timestamp":1357873906000},"page":"1790-1796","source":"Crossref","is-referenced-by-count":61,"title":["Thrombocytosis and Hepatocellular Carcinoma"],"prefix":"10.1007","volume":"58","author":[{"given":"Brian I.","family":"Carr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,12]]},"reference":[{"key":"2527_CR1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Establishment of world-wide burden of cancer in 2008: GLOBCAN 2008. Int J Cancer. 2010;127:2893\u20132917.","journal-title":"Int J Cancer"},{"key":"2527_CR2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.patbio.2010.01.005","volume":"58","author":"MC Kew","year":"2010","unstructured":"Kew MC. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol (Paris). 2010;58:273\u2013277.","journal-title":"Pathol Biol (Paris)"},{"key":"2527_CR3","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","volume":"22","author":"RP Beasely","year":"1981","unstructured":"Beasely RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and HBV: a prospective study of 22,000 men in Taiwan. Lancet. 1981;22:1129\u20131133.","journal-title":"Lancet"},{"key":"2527_CR4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/carcin\/bgp264","volume":"31","author":"CP Wild","year":"2010","unstructured":"Wild CP, Gong YY. Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis. 2010;31:71\u201382.","journal-title":"Carcinogenesis"},{"key":"2527_CR5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02672256","volume":"6","author":"SZ Yu","year":"1994","unstructured":"Yu SZ, Chen G. Blue-green algae toxins and liver cancer. China J Cancer Res. 1994;6:9\u201317.","journal-title":"China J Cancer Res"},{"key":"2527_CR6","first-page":"203","volume":"234","author":"TL Zhou","year":"1990","unstructured":"Zhou TL, Yu SZ. Laboratory study on the relationship between drinking water and hepatoma. Quantitative evaluation using GGT method. Zhonghua Yu Fang Yi Xue Za Zhi. 1990;234:203\u2013205.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"2527_CR7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1478-3231.2003.00869.x","volume":"23","author":"MC Kew","year":"2003","unstructured":"Kew MC. Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. Liver Int. 2003;23:405\u2013440.","journal-title":"Liver Int"},{"key":"2527_CR8","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/jnci\/djp288","volume":"101","author":"MH Chang","year":"2009","unstructured":"Chang MH, You SL, Chen CJ, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst. 2009;101:1348\u20131355.","journal-title":"J Natl Cancer Inst"},{"key":"2527_CR9","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/cncr.22242","volume":"107","author":"SN Lu","year":"2006","unstructured":"Lu SN, Wang JH, Liu SL, et al. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Cancer. 2006;107:2212\u20132222.","journal-title":"Cancer"},{"key":"2527_CR10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/jmv.21686","volume":"82","author":"T Kumada","year":"2010","unstructured":"Kumada T, Toyoda H, Kiriyama S, et al. Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values. J Med Virol. 2010;82:539\u2013545.","journal-title":"J Med Virol"},{"key":"2527_CR11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.gastro.2008.09.014","volume":"136","author":"AS Lok","year":"2009","unstructured":"Lok AS, Seeff LB, Morgan TR, HALT-C Trial Group, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology. 2009;136:138\u2013148.","journal-title":"Gastroenterology"},{"key":"2527_CR12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000342431","volume":"83","author":"BI Carr","year":"2012","unstructured":"Carr BI, Guerra V, Pancoska P. Thrombocytopenia in relation to tumor size in patients with hepatocellular carcinoma. Oncology.. 2012;83:339\u2013345.","journal-title":"Oncology"},{"key":"2527_CR13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000341533","volume":"83","author":"BI Carr","year":"2012","unstructured":"Carr BI, Guerra V, De Giorgio M, Fagiuoli S, Pancoska P. Small hepatocellular carcinomas and thrombocytopenia. Oncology. 2012;83:331\u2013338.","journal-title":"Oncology"},{"key":"2527_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/ajcp\/105.1.65","volume":"105","author":"UC Nzeako","year":"1996","unstructured":"Nzeako UC, Goodman ZD, Ishak KG. Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinic-histopathologic study of 804 North American patients. Am J Clin Pathol. 1996;105:65\u201375.","journal-title":"Am J Clin Pathol"},{"key":"2527_CR15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0016-5085(89)91427-3","volume":"97","author":"K Okuda","year":"1989","unstructured":"Okuda K, Nakashima T, Kojiro M, et al. Hepatocellular carcinoma without cirrhosis in Japanese patients. Gastroenterology. 1989;97:140\u2013146.","journal-title":"Gastroenterology"},{"key":"2527_CR16","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/1097-0142(19950501)75:9<2220::AID-CNCR2820750906>3.0.CO;2-4","volume":"75","author":"F Trevisani","year":"1995","unstructured":"Trevisani F, D\u2019Intino PE, Caraceni P, et al. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients. Cancer. 1995;75:2220\u20132232.","journal-title":"Cancer"},{"key":"2527_CR17","unstructured":"Truant S, Boleslawsky E, Duhamel A, et al. Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resection. Eur J Surg Oncol. 2012. Epub. 08\/03\/2012."},{"key":"2527_CR18","volume-title":"Lectures on Clinical Medicine","author":"A Trousseau","year":"1867","unstructured":"Trousseau A, Bazine V, Cormack J. Lectures on Clinical Medicine. USA: R. Hardwicke; 1867."},{"key":"2527_CR19","first-page":"237","volume":"39","author":"L Riess","year":"1872","unstructured":"Riess L. Zur pathologischen anatomie des blutes. Arch Anat Physiol Wissensch Med. 1872;39:237\u2013249.","journal-title":"Arch Anat Physiol Wissensch Med"},{"key":"2527_CR20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archinte.1964.03860100079008","volume":"114","author":"J Levin","year":"1964","unstructured":"Levin J, Conley CL. Thrombocytosis associated with malignant disease. Arch Int Med. 1964;114:497\u2013500.","journal-title":"Arch Int Med"},{"key":"2527_CR21","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.3748\/wjg.v10.i17.2472","volume":"10","author":"SJ Hwang","year":"2004","unstructured":"Hwang SJ, Luo JC, Li CP, et al. Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma. World J Gastroenterol. 2004;10:2472\u20132477.","journal-title":"World J Gastroenterol"},{"key":"2527_CR22","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/annonc\/mdi171","volume":"16","author":"CC Chen","year":"2005","unstructured":"Chen CC, Chang JY, Liu KJ, et al. Hepatocellular carcinoma associated with acquired von Willebrand disease and extreme thrombocytosis. Ann Oncol. 2005;16:988\u2013989.","journal-title":"Ann Oncol"},{"key":"2527_CR23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/1097-0142(19800115)45:2<315::AID-CNCR2820450219>3.0.CO;2-W","volume":"45","author":"HJ Nickerson","year":"1980","unstructured":"Nickerson HJ, Silberman TL, McDonald TP. Hepatoblastoma, thrombocytosis, and increased thrombopoietin. Cancer. 1980;45:315\u2013317.","journal-title":"Cancer"},{"key":"2527_CR24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MPH.0b013e31818b3784","volume":"31","author":"CC Hsiao","year":"2009","unstructured":"Hsiao CC, Chuang JH, Tiao MM, et al. Patterns of hepatoblastoma and hepatocellular carcinoma in children after universal hepatitis B vaccination in Taiwan: a report from a single institution in southern Taiwan. J Pediatr Hematol Oncol. 2009;31:91\u201396.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2527_CR25","first-page":"79","volume":"32","author":"CY Kuo","year":"1991","unstructured":"Kuo CY, Liu HC, Chang MH, et al. Hepatoblastoma in infancy and childhood: a clinical and pathological study of 32 cases. Zhonghua Min Guo Xiao. 1991;32:79\u201387.","journal-title":"Zhonghua Min Guo Xiao"},{"key":"2527_CR26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/stem.160329","volume":"16","author":"E Komura","year":"1998","unstructured":"Komura E, Matsumura T, Kato T, et al. Thrombopoietin in patients with hepatoblastoma. Stem Cells. 1998;16:329\u2013333.","journal-title":"Stem Cells"},{"key":"2527_CR27","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","volume":"366","author":"RL Stone","year":"2012","unstructured":"Stone RL, Nick AM, McNeish IA, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012;366:610\u2013618.","journal-title":"N Engl J Med"},{"key":"2527_CR28","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20:576\u2013590.","journal-title":"Cancer Cell"},{"key":"2527_CR29","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/ijc.27441","volume":"130","author":"D Buergy","year":"2012","unstructured":"Buergy D, Wenz F, Groden C, Brockmann MA. Tumor-platelet interactions in solid tumors. Int J Cancer. 2012;130:2747\u20132760.","journal-title":"Int J Cancer"},{"key":"2527_CR30","unstructured":"Cho MS, Bottsford-Miller J, Vasquez HG, et al. Platelets increase the proliferation of ovarian cancer cells. Blood. 2012. Epub. 09\/10\/2012."},{"key":"2527_CR31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10456-012-9259-z","volume":"15","author":"JE Peterson","year":"2012","unstructured":"Peterson JE, Zurakowski D, Italiano JE Jr, et al. VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients. Angiogenesis. 2012;15:265\u2013273.","journal-title":"Angiogenesis"},{"key":"2527_CR32","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/00042737-200107000-00006","volume":"13","author":"W Jelkmann","year":"2001","unstructured":"Jelkmann W. The role of the liver in the production of thrombopoietin compared with erythropoietin. Eur J Gastroenterol Hepatol. 2001;13:791\u2013801.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2527_CR33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1042\/CS20000023","volume":"99","author":"M Okubo","year":"2000","unstructured":"Okubo M, Shiota G, Kawasaki H. Thrombopoietin levels in serum and liver tissue in patients with chronic viral hepatitis and hepatocellular carcinoma. Clin Sci (Lond). 2000;99:207\u2013214.","journal-title":"Clin Sci (Lond)"},{"key":"2527_CR34","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2741\/s348","volume":"4","author":"MA Nalesnik","year":"2012","unstructured":"Nalesnik MA, Michalopoulos GK. Growth factor pathways in development and progression of hepatocellular carcinoma. Front Biosci (School Educ). 2012;4:1487\u20131515.","journal-title":"Front Biosci (School Educ)"},{"key":"2527_CR35","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.bbrc.2006.06.007","volume":"346","author":"ZF Yang","year":"2006","unstructured":"Yang ZF, Ho DW, Lau CK, et al. Platelet activation during tumor development, the potential role of BDNF\u2013TrkB autocrine loop. Biochem Biophys Res Commun. 2006;346:981\u2013985.","journal-title":"Biochem Biophys Res Commun"},{"key":"2527_CR36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s004320050009","volume":"126","author":"J Zhou","year":"2000","unstructured":"Zhou J, Tang YZ, Fan J, et al. Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus. J Cancer Res Clin Oncol. 2000;126:57\u201361.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2527_CR37","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1038\/sj.onc.1209083","volume":"25","author":"J Gotzmann","year":"2006","unstructured":"Gotzmann J, Fischer AN, Zoler M, et al. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. Oncogene. 2006;25:3170\u20133185.","journal-title":"Oncogene"},{"key":"2527_CR38","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1158\/1535-7163.MCT-06-0720","volume":"6","author":"P Stock","year":"2007","unstructured":"Stock P, Monga D, Tan X, et al. Platelet-derived growth factor receptor-alpha: a novel therapeutic target in human hepatocellular cancer. Mol Cancer Ther. 2007;6:1932\u20131941.","journal-title":"Mol Cancer Ther"},{"key":"2527_CR39","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/ijc.25469","volume":"128","author":"T Maass","year":"2011","unstructured":"Maass T, Thieringer FR, Mann A, et al. Liver specific overexpression of platelet-derived growth factor-B accelerates liver cancer development in chemically induced liver carcinogenesis. Int J Cancer. 2011;128:1259\u20131268.","journal-title":"Int J Cancer"},{"key":"2527_CR40","unstructured":"Okada H, Honda M, Campbell JS, et al. Acyclic retinoid targets platelet-derived growth factor signaling in the prevention of hepatic fibrosis and hepatocellular carcinoma development. Cancer Res. 2012. Epub. 05\/31\/2012."},{"key":"2527_CR41","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1073\/pnas.0409722102","volume":"102","author":"JS Campbell","year":"2005","unstructured":"Campbell JS, Hughes SD, Gilbertson DG, et al. Platelet-derived growth factor C induces liver fibrosis, steatosis and hepatocellular carcinoma. Proc Natl Acad Sci USA. 2005;102:3389\u20133394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2527_CR42","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/hep.23441","volume":"51","author":"C Soll","year":"2010","unstructured":"Soll C, Jang JH, Riener MD, et al. Serotonin promotes tumor growth in human hepatocellular cancer. Hepatology. 2010;51:1244\u20131254.","journal-title":"Hepatology"},{"key":"2527_CR43","unstructured":"Lesurtel M, Clavien P-A. Serotonin: a key molecule in acute and chronic liver injury. Clin Res Hepatol Gastroenterol. 2012. Epub. 06\/29\/2012."},{"key":"2527_CR44","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/hep.24099","volume":"53","author":"C Gauglhofer","year":"2011","unstructured":"Gauglhofer C, Sagmeister S, Schrottmaier W, et al. Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis. Hepatology. 2011;53:854\u2013864.","journal-title":"Hepatology"},{"key":"2527_CR45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2407-12-56","volume":"12","author":"S Miura","year":"2001","unstructured":"Miura S, Mitsuhashi N, Shimizu H, et al. Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma. BMC Cancer. 2001;12:56.","journal-title":"BMC Cancer"},{"key":"2527_CR46","doi-asserted-by":"crossref","first-page":"e36713","DOI":"10.1371\/journal.pone.0036713","volume":"7","author":"DM French","year":"2012","unstructured":"French DM, Lin BC, Wang M, et al. Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models. PLoS One. 2012;7:e36713.","journal-title":"PLoS One"},{"key":"2527_CR47","doi-asserted-by":"crossref","unstructured":"Sitia G, Aiolfi R, Di Lucia P, et al. Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proc Natl Acad Sci USA. 2012;109:E2165\u2013E2172. Epub. 07\/02\/2012.","DOI":"10.1073\/pnas.1209182109"},{"key":"2527_CR48","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1161\/ATVBAHA.110.207514","volume":"30","author":"S Jain","year":"2010","unstructured":"Jain S, Harris J, Ware J. Platelets: linking hemostasis and cancer. Arter Thromb Vasc Biol. 2010;30:2362\u20132367.","journal-title":"Arter Thromb Vasc Biol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-012-2527-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-012-2527-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-012-2527-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T01:36:42Z","timestamp":1562549802000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-012-2527-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,12]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["2527"],"URL":"https:\/\/doi.org\/10.1007\/s10620-012-2527-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,12]]}}}